Article Access statistics

Viewed: 490

Emailed: 0

PDF Downloaded: 143

IP Journal of Diagnostic Pathology and Oncology


Significance of neutrophil to lymphocyte ratio in prostate lesions with special reference to prostate cancer


Full Text PDF Share on Facebook Share on Twitter


Author Details : Sushma Shankar, Argha Baruah, C.S.B.R. Prasad

Volume : 3, Issue : 2, Year : 2018

Article Page : 96-100


Suggest article by email

Abstract

Aim: To study the significance of neutrophil- lymphocyte ratio (N:L ratio) in prostate lesions, especially in cases of prostate cancer (PCa).
Materials and Methods: Fifty cases of PCa and fifty cases of benign prostatic hyperplasia (BPH), diagnosed on transurethral resection of prostate biopsies were included in the study. Hematological parameters were recorded, N:L ratio was calculated in all cases and values were compared between BPH and PCa, further association between pathological characters of PCa and N:L ratio values was studied.
Results: In the present study, we found a statistically significant high N:L ratio in PCa cases as compared with BPH cases (p=0.008). We also found a significant difference in the PSA values (p<0.001) and ESR (0.001) between the benign and malignant groups. However hemoglobin, platelet counts and total leucocyte counts did not show a significant difference between the two groups. Sub group analysis failed to show an association between prognostic markers like PSA (p=0.838), gleason score (p=0.161), T (p=0.052) N (p=0.225) M (p=0.529) stage and N:L ratio.
Conclusion: In this study, significant difference in N:L ratio was noted between BPH and PCa, but no association could be demonstrated between N:L ratio and prognostic markers in PCa. Hence N:L ratio cannot be used as a prognostic marker in PCa.

Keywords: Prostate cancer (PCa), N:L ratio.

Doi : 10.18231/2581-3706.2018.0021

How to cite : Shankar S, Baruah A, Prasad C, Significance of neutrophil to lymphocyte ratio in prostate lesions with special reference to prostate cancer. IP J Diagn Pathol Oncol 2018;3(2):96-100

Copyright © 2018 by author(s) and IP J Diagn Pathol Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)